MedPath

Association Between Pseudoexfoliation Syndrome and Diabetes Mellitus

Conditions
Lens Diseases
Interventions
Device: slit lamp
Registration Number
NCT03741153
Lead Sponsor
Assiut University
Brief Summary

Pseudoexfoliation syndrome (PEX) is characterized by the deposition of a distinctive fibrillar material in the anterior segment of the eye and was first described in 1917 by Lindberg. It is frequently associated with open angle glaucoma, known as pseudoexfoliation glaucoma, which is one of the most common identifiable forms of secondary open angle glaucoma worldwide. Despite extensive research, the exactchemical nature of the fibrillar material is unknown. It is believed to be secreted multifocally in the iris pigment epithelium, the ciliary epithelium, and the peripheral anterior lens epithelium.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Phakic patients presenting to Ophthalmology outpatient clinic Of Assiut University Hospital.
Exclusion Criteria
  • Patients with previous intraocular surgery.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
control groupslit lampage matched controls who do not have Pseudoexfoliation syndrome
study groupslit lampincludes patients who will be diagnosed with Pseudoexfoliation syndrome
Primary Outcome Measures
NameTimeMethod
the percentage of diabetic patients with pseudo-exfoliation syndrome10 minutes

slit lamp examination of all diabetic patients to get the percentage of those with pseudo-exfoliation syndrome

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath